Diamyd Medical AB (publ) (DMYD-B) - Cash Flow Conversion Efficiency

Latest as of May 2026: -0.276x

Based on the latest financial reports, Diamyd Medical AB (publ) (DMYD-B) has a cash flow conversion efficiency ratio of -0.276x as of May 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-71.70 Million ≈ $-7.72 Million USD) by net assets (Skr259.39 Million ≈ $27.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Diamyd Medical AB (publ) stock valuation for the company's overall valuation and market capitalisation.

Diamyd Medical AB (publ) - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Diamyd Medical AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Diamyd Medical AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Diamyd Medical AB (publ) ranked by their cash flow conversion efficiency. Explore Diamyd Medical AB (publ) cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Cordoba Minerals Corp V:CDB	14.511x
FAWER Automotive Parts Ltd Co SHE:200030	0.027x
Amj Land Holdings Limited NSE:AMJLAND	0.044x
Kier Group PLC LSE:KIE	-0.048x
Eden Innovations Ltd AU:EDE	0.987x
Carlin Gold Corporation V:CGD	-0.013x
Ateliers Mecaniques D’Indonesie Tbk PT JK:AMIN	0.114x
FINEDIGITAL Inc KQ:038950	0.008x

Annual Cash Flow Conversion Efficiency for Diamyd Medical AB (publ) (2010–2025)

The table below shows the annual cash flow conversion efficiency of Diamyd Medical AB (publ) from 2010 to 2025. View DMYD-B stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-08-31	Skr280.00 Million ≈ $30.13 Million	Skr-169.68 Million ≈ $-18.26 Million	-0.606x	+31.55%
2024-08-31	Skr145.92 Million ≈ $15.70 Million	Skr-129.18 Million ≈ $-13.90 Million	-0.885x	-35.15%
2023-08-31	Skr169.40 Million ≈ $18.23 Million	Skr-110.96 Million ≈ $-11.94 Million	-0.655x	-50.64%
2022-08-31	Skr214.38 Million ≈ $23.07 Million	Skr-93.22 Million ≈ $-10.03 Million	-0.435x	+24.82%
2021-08-31	Skr189.26 Million ≈ $20.37 Million	Skr-109.47 Million ≈ $-11.78 Million	-0.578x	-348.38%
2020-08-31	Skr72.49 Million ≈ $7.80 Million	Skr16.88 Million ≈ $1.82 Million	0.233x	+137.31%
2019-08-31	Skr62.78 Million ≈ $6.76 Million	Skr-39.19 Million ≈ $-4.22 Million	-0.624x	+35.41%
2018-08-31	Skr43.01 Million ≈ $4.63 Million	Skr-41.56 Million ≈ $-4.47 Million	-0.966x	-224.51%
2017-08-31	Skr86.67 Million ≈ $9.33 Million	Skr-25.81 Million ≈ $-2.78 Million	-0.298x	+50.91%
2016-08-31	Skr29.26 Million ≈ $3.15 Million	Skr-17.75 Million ≈ $-1.91 Million	-0.607x	-30.94%
2015-08-31	Skr39.52 Million ≈ $4.25 Million	Skr-18.31 Million ≈ $-1.97 Million	-0.463x	-22.60%
2014-08-31	Skr44.16 Million ≈ $4.75 Million	Skr-16.69 Million ≈ $-1.80 Million	-0.378x	-66.13%
2013-08-31	Skr60.29 Million ≈ $6.49 Million	Skr-13.71 Million ≈ $-1.48 Million	-0.227x	-66.41%
2012-08-31	Skr409.58 Million ≈ $44.08 Million	Skr-55.99 Million ≈ $-6.03 Million	-0.137x	+32.98%
2011-08-31	Skr460.97 Million ≈ $49.61 Million	Skr-94.03 Million ≈ $-10.12 Million	-0.204x	-128.44%
2010-08-31	Skr314.78 Million ≈ $33.88 Million	Skr225.77 Million ≈ $24.30 Million	0.717x	--

About Diamyd Medical AB (publ)

ST:DMYD-B Sweden Biotechnology

Market Cap

$16.46 Million

Skr153.00 Million SEK

Market Cap Rank

#25803 Global

#523 in Sweden

Share Price

Skr1.01

Change (1 day)

+0.60%

52-Week Range

Skr1.00 - Skr17.62

All Time High

Skr71.00